HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: 290/6/R1751    most recent 00019.2006v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yuhki, K.-i. Articles by Ushikubi, F. Search for Related Content PubMed Articles by Yuhki, K.-i. Articles by Ushikubi, F.

LETTERS TO THE EDITOR

Role of Prostanoids in Inflammatory Tachycardia: A Reply to the Letter of Dr. Eugene Nalivaiko

Department of Pharmacology
Asahikawa Medical College
Midorigaoka Higashi

Asahikawa 078-8510, Japan
E-mail: ushikubi{at}asahikawa-med.ac.jp

Dr. Nalivaiko discussed the role of the sympathetic nervous system in inflammatory tachycardia, tachycardia observed under inflammatory conditions, citing our resent study (4) as a reference. In fact, inflammatory tachycardia has long been thought to result from increased sympathetic activity brought by inflammatory signals. However, we presented another novel mechanism leading to inflammatory tachycardia in mice: PGF₂ and thromboxane A₂ (TXA₂) play mediatory roles in the phenomenon (4). In short, these prostanoids increased beating rates of isolated atria in a concentration-dependent manner via their respective receptors, the FP and TP. In addition, the inflammatory cytokine-induced increase in beating rate of isolated atria was totally dependent on both the FP and TP, indicating that inflammatory cytokines stimulated local production of PGF₂ and TXA₂ and thus induced tachycardia. Furthermore, LPS, a potent inducer of systemic inflammation through the production of inflammatory cytokines, failed to induce tachycardia in mice lacking both the FP and TP, confirming the in vivo role of PGF₂ and TXA₂ in inflammatory tachycardia.

In our model of LPS-induced tachycardia, a -adrenergic blocker significantly reduced heart rate by 100 beats/min, but failed to affect the biphasic pattern of tachycardia itself, indicating that the prostanoids have a distinctive role in inflammatory tachycardia independent of the sympathetic nervous system. This result presents an important suggestion to evaluate the effect of beta blockers on tachycardia. Because the sympathetic nervous system is a main constituent determining basal and demand-dependent heart rate, any beta blocker would usually reduce heart rate under various situations, as seen also in our model. Therefore, it seems important to observe the pattern of tachycardia after the administration of beta blockers to properly evaluate their effects. In this mean, previous studies might have failed to detect the factors mediating inflammatory tachycardia other than the sympathetic nervous system due to an apparent inhibitory effect of beta blockers on heart rate at a single observation time point. In another aspect, it would be very difficult to demonstrate increased sympathetic discharge leading to tachycardia by use of beta blockers because they inhibit basal sympathetic tone in addition to the increased tone under inflammatory conditions.

Dr. Nalivaiko indicated the difference in the dose of LPS used between in his rabbit study (3) and in our mouse study (4), and suggested that the sympathetic nervous system and the prostanoids may participate in inflammatory tachycardia differently according to an extent of inflammation. It is noteworthy, however, that rabbits show the highest sensitivity to LPS but mice show the lowest one. Therefore, to discuss the difference in dose dependent effects of LPS between rabbits and mice is difficult, and further studies using a single species would be required to clarify the issue.

We found that a pattern of LPS-induced tachycardia in mice lacking the PGE₂ receptor EP₃ [these mice showed a defective febrile response to LPS (5)] was nevertheless similar to that in wild-type mice. This result clearly indicates that febrile response and inflammatory tachycardia are independent events mediated by the different prostanoids and that fever itself could not induce tachycardia, which is in sharp contrast with a previous idea. The effect of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and indomethacin, on heart rate results from a reduction in sympathetic tone caused by their antipyretic action. Interestingly, there are two pioneering human studies reporting a potent suppressive effect of NSAIDs on both inflammatory tachycardia and febrile response under inflammatory conditions (1, 2). Considering an independence of inflammatory tachycardia and febrile response found in mice, these reports suggest that the prostanoids play a role in inflammatory tachycardia also in humans. However, roles of the prostanoids and sympathetic nervous system in inflammatory tachycardia in humans remain to be clarified in future studies.

REFERENCES

1. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, and Swindell BB. The effects of ibuprofen on the physiology and survival of patients with sepsis. The ibuprofen in sepsis study group. N Engl J Med 336: 912–918, 1997.[Abstract/Free Full Text]
2. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, and Wilmore DW. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318: 1481–1486, 1988.[Abstract]
3. Nalivaiko E, Ootsuka Y, and Blessing WW. Activation of 5-HT_1A receptors in the medullary raphe reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits. Am J Physiol Regul Integr Comp Physiol 289: R596–R604, 2005.[Abstract/Free Full Text]
4. Takayama K, Yuhki K, Ono K, Fujino T, Hara A, Yamada T, Kuriyama S, Karibe H, Okada Y, Takahata O, Taniguchi T, Iijima T, Iwasaki H, Narumiya S, and Ushikubi F. Thromboxane A₂ and prostaglandin F₂ mediate inflammatory tachycardia. Nat Med 11: 562–566, 2005.[CrossRef][ISI][Medline]
5. Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, Hizaki H, Tuboi K, Katsuyama M, Ichikawa A, Tanaka T, Yoshida N, and Narumiya S. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP₃. Nature 395: 281–284, 1998.[CrossRef][Medline]

This Article Full Text (PDF) All Versions of this Article: 290/6/R1751    most recent 00019.2006v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yuhki, K.-i. Articles by Ushikubi, F. Search for Related Content PubMed Articles by Yuhki, K.-i. Articles by Ushikubi, F.